Literature DB >> 14999738

Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.

Nazrul Islam1, Peter Stewart, Ian Larson, Patrick Hartley.   

Abstract

The objective of this study was to determine the influence of lactose carrier size on drug dispersion of salmeterol xinafoate (SX) from interactive mixtures. SX dispersion was measured by using the fine particle fractions determined by a twin stage impinger attached to a Rotahaler. The particle size of the lactose carrier in the SX interactive mixtures was varied using a range of commercial inhalation-grade lactoses. In addition, differing size fractions of individual lactose samples were achieved by dry sieving. The dispersion of SX appeared to increase as the particle size of the lactose carrier decreased for the mixtures prepared from different particle size commercial samples of lactose and from different sieve fractions of the same lactose. Fine particles of lactose (<5 microm) associated with the lactose carrier were removed from the carrier surface by a wet decantation process to produce lactose samples with low but similar concentrations of fine lactose particles. The fine particle fractions of SX in mixtures prepared with the decanted lactose decreased significantly (analysis of variance, p < 0.001) and the degree of dispersion became independent of the volume mean diameter of the carriers (analysis of variance, p < 0.05). The dispersion behavior is therefore associated with the presence of fine adhered particles associated with the carriers and the inherent size of the carrier itself has little influence on dispersion. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999738     DOI: 10.1002/jps.10583

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.

Authors:  V N P Le; T H Hoang Thi; E Robins; M P Flament
Journal:  AAPS PharmSciTech       Date:  2012-03-08       Impact factor: 3.246

2.  Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.

Authors:  Handoko Adi; Ian Larson; Herbert Chiou; Paul Young; Daniela Traini; Peter Stewart
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

Review 3.  The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.

Authors:  Matthew D Jones; Robert Price
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 4.  Particle size analysis in pharmaceutics: principles, methods and applications.

Authors:  Boris Y Shekunov; Pratibhash Chattopadhyay; Henry H Y Tong; Albert H L Chow
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

5.  The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.

Authors:  Susan Hoe; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

6.  Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation.

Authors:  Nazrul Islam; Emma Cichero; Shafiqur Rahman; Isuru Ranasinghe
Journal:  Am J Cardiovasc Drugs       Date:  2022-10-18       Impact factor: 3.283

Review 7.  In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.

Authors:  Sau Lawrence Lee; Wallace P Adams; Bing V Li; Dale P Conner; Badrul A Chowdhury; Lawrence X Yu
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

8.  Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.

Authors:  Rinku A Tuli; Graeme A George; Tim R Dargaville; Nazrul Islam
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

9.  Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization.

Authors:  Md Abdur Rashid; Saiqa Muneer; Tony Wang; Yahya Alhamhoom; Llew Rintoul; Emad L Izake; Nazrul Islam
Journal:  PLoS One       Date:  2021-04-13       Impact factor: 3.240

Review 10.  Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections.

Authors:  Mohammad Zaidur Rahman Sabuj; Nazrul Islam
Journal:  Nanoscale Adv       Date:  2021-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.